A naloxone vending machine is a dispenser that gives out the opioid-overdose reversal medicine naloxone, usually free, at hours and in places where a pharmacy or health service is closed or not wanted. Public-health programs run them; the machine is the cheapest part of the program. This page explains the legal position in the US and Australia (as of October 2026), how programs choose sites and access rules, what the label means for the cabinet, and what the evidence shows. For the policy background and a published government tender’s requirements, read our harm reduction vending machines post first; this page goes deeper on running one.
Quick answer
- US: Narcan 4 mg nasal spray became over-the-counter on 29 March 2023, and RiVive 3 mg on 28 July 2023. OTC products can be vended or given away without a prescription.
- Australia: naloxone has been free without prescription under the national Take Home Naloxone (THN) program since 1 July 2022. States and territories decide the non-pharmacy settings, so a machine runs inside an approved supplier’s program.
- Programs are usually free to the user, and are run by health departments, harm-reduction services, universities and other community health programs.
- Storage: 2–25 °C, never frozen, no heat above 40 °C, protected from light (current US Narcan label). Site the cabinet indoors or specify active temperature control and monitoring.
- Access: anonymous or near-anonymous, one controlled unit per vend, every vend logged for the funder.
- Evidence: associated with fewer overdose deaths in one county study; high acceptability and use outside business hours across reviews.
What a naloxone vending machine is, and what it is not
It is a controlled dispenser: the user selects, the machine pushes one carton into a delivery bin, and the stock stays locked away. It is not a pharmacy and not a training session. Most programs add the missing pieces around it: instructions on the panel, a QR code to a short training video, and a phone number for the local service.
The products in these machines are usually naloxone plus other harm-reduction supplies. Published US programs stock fentanyl and xylazine test strips, sterile injecting equipment, wound-care and hygiene kits and safer-sex supplies alongside naloxone.
Is it legal to vend naloxone?
This is a summary for planning, not legal advice. Rules change; confirm with the regulator where the machine will stand.
| Jurisdiction | Position (as of October 2026) | What it means for a machine |
|---|---|---|
| United States | FDA approved Narcan 4 mg nasal spray for OTC sale on 29 March 2023, for sale in drug stores, convenience and grocery stores, gas stations and online, and RiVive 3 mg (Harm Reduction Therapeutics) on 28 July 2023 | OTC-labelled products can be vended or given away. Other naloxone products may remain prescription-only; check the label of the product you stock |
| Australia | National THN program: free, no prescription, from 1 July 2022, for anyone who may experience or witness an opioid overdose. Supplied by approved providers (pharmacists, dispensing doctors, hospital pharmacists) and Authorised Alternative Suppliers such as needle and syringe programs | Each state or territory decides where naloxone is available in non-pharmacy settings. A machine operates as part of an approved supplier’s program, not on its own |
| Elsewhere | Varies by medicines schedule | Ask the medicines regulator whether unattended supply is allowed, by whom and with what record |
KioskForce builds the machine to the requirement you state — release method, limits, records and temperature configuration — and writes it into the quotation. We do not certify that a machine complies with any medicines law, and we do not claim regulatory approval for any product category. The medicine vending hub sets out that position in full, and the medicine vending legality guide covers other product groups.
Who runs them, and where
| Setting | Published example | What was reported |
|---|---|---|
| Syringe services program | Trac-B Exchange, Clark County, Nevada: three public health vending machines from 2017, naloxone added in 2019 | 229 opioid overdose deaths in the 12 months after naloxone was added, against 270 forecast (Allen et al., 2022) |
| University | A large Midwestern university; campus machine with free naloxone and reduced-price emergency contraception | Naloxone was the most-dispensed product: 297 units, October 2024 – May 2025 (Paa et al., 2026) |
| Australia | Government procurement of naloxone dispensing machines for needle and syringe programs, described in our harm reduction post | Requirements included controlled dispensing, a per-transaction limit, temperature control and program data |
How the access rules are chosen
The design tension is that funders want data, while the people most likely to need naloxone often avoid anything that identifies them. A 2023 scoping review of harm-reduction vending machines (Russell et al., Harm Reduction Journal) recommends maximising access up to 24 hours a day, 7 days a week, allowing anonymous use, and making sure the machine can collect data. In practice programs pick one of four access models:
| Access model | Friction | Data it yields | When to use it |
|---|---|---|---|
| Free push-button, one unit per vend | None | Units by machine, time and product | Default for community sites |
| Push-button plus an anonymous on-screen question (for example, first supply or refill) | Seconds | Units plus self-reported evaluation data | When the funder needs outcome indicators |
| Program card, barcode or code | One-off registration with the service | Unique users, repeat use | Where the service already registers clients, such as a clinic system |
| Staff-released | High | Full record | Only where the rule requires a person to authorise supply |
Whatever the model, keep personal data off the machine. On our public health builds, registration happens on a separate web portal, the machine only sees a code or token, and per-user limits are counted against that token in the cloud. The same architecture runs our HIV self-test vending deployments.
What the label means for the cabinet
Naloxone is a medicine with storage conditions, and a vending cabinet in a hot stairwell or an unheated shelter can break them. The current US Narcan label on DailyMed gives the limits (earlier 2023 prescribing information worded them slightly differently, so check the label of the exact product you stock):
| Label statement (Narcan Nasal Spray, current US label) | What it means for siting and specification |
|---|---|
| Store at room temperature or refrigerated, 2–25 °C (36–77 °F) | Indoor, conditioned positions are the safe default; refrigeration is allowed but not required |
| Avoid excessive heat above 40 °C (104 °F) | Hot stairwells, sun-facing glass and unventilated shelters are the risk, which is why logging matters: you need to know how long and how high |
| Do not freeze (the 2023 prescribing information adds that a device frozen below about −15 °C will not spray) | Unheated outdoor cabinets in cold climates are a real risk |
| Protect from light; keep in the box until use | Dispense the carton, not loose devices; avoid clear-fronted stock areas in sunlight |
| Supplied as a carton of two blister packs, each with one spray device | Size coils to the carton as loaded; one vend usually means two doses |
Check the label of the exact product you stock; other products may differ.
Our hardware options here are plain. Compact wall-mount machines are ambient — they rely on the room. The floor-standing KF10X22, BG10X10 and KF6X10 are available refrigerated (R290 or R134a) or ambient. Optional temperature monitoring with alerts can be fitted, and our cloud backend can log temperature alongside dispense data. For naloxone the usual answer is an ambient wall-mount cabinet in a conditioned indoor position, with a temperature sensor that alerts at your chosen thresholds. If the only available position is outdoors, tell us the site’s temperature range and we will discuss the options before quoting.
Stock, expiry and restocking
- Coil sizing. Our public health configurations use 60–80 mm coils for naloxone cartons. Send the carton dimensions as loaded.
- Per-vend limit. Many programs cap a vend at one or two cartons and allow repeat vends; set the limit at enquiry.
- Expiry. Naloxone carries an expiry date on the box. Load first-expiring stock at the front of each coil and record the expiry when restocking; the restocking interface lets staff monitor stock and expiry dates.
- Low-stock alerts. The cloud dashboard shows live stock per machine. An empty naloxone machine is a failure that can cost a life, so set alerts early enough for the restock route.
- Help label. Put the service phone number and the machine’s ID on the cabinet so users can report a fault.
What data should a naloxone machine record?
| Record | Why the funder wants it |
|---|---|
| Units by product, machine, date and time | Reach, and when demand happens; reviews consistently find most use outside business hours |
| Optional anonymous answers (first supply or refill; used naloxone since last visit) | Program outcome indicators |
| Stock levels and stock-outs | Service reliability |
| Temperature log and excursions | Product integrity |
| Downtime and faults | Contract performance |
Every dispense on our machines writes an order record with items, quantities, machine, location, time, order state and receipt ID. Identity is attached only if your rule requires it.
What does the evidence say?
- Overdose deaths. Allen et al. (2022) used death-certificate data for Clark County residents from 2015 to 2020. In the 12 months after naloxone was added to the county’s public health vending machines, 229 opioid overdose deaths occurred against 270 forecast, suggesting 41 averted, and there was a significant immediate drop at launch. The authors’ forecasts into the COVID-19 period showed worsening trends.
- Feasibility and acceptability. A 2025 systematic review (Zhang et al.) covered 45 articles on 30 studies of harm-reduction vending machines. It found high demand, use mostly outside business hours and general acceptance by target populations. Impact evidence was limited: two articles reported fewer fatal overdoses after naloxone machines were introduced.
- Campus demand. At one Midwestern university, naloxone was the most-dispensed product in a health vending machine, ahead of emergency contraception (Paa et al., 2026).
Programs should plan their own evaluation from day one; the published base is still small.
What to specify if you are buying one
- The product(s) and carton dimensions, and any other harm-reduction items to share the cabinet.
- Your supply authority: who is the approved supplier or program operator, and what the rule requires per vend.
- The access model from the table above, and the per-vend limit.
- The site’s temperature range, and whether you need monitoring and alerts.
- What must be recorded for the funder, and who reads it.
- Mounting and security: wall type, indoor or sheltered, hours of access.
- Number of sites and the restock route.
Start with the compact wall-mount machine, published at about US$800–1,500 per unit, and the cost guide. Free vend, codes and cashless options are on payments. Hardware and software are designed in-house, and we sell direct and, in some regions, through local distributors. Lead times run about 4–6 weeks for a modified standard machine and 8–12 weeks for a custom design. On-site installation is optional and, in some regions, provided through a local distributor, who then handles warranty and service; our support is by email.
Where a naloxone vending machine is the wrong answer
- Where your supply route is not yet authorised. In Australia, if your state or territory has not set out how a non-pharmacy setting may supply under THN, settle that first.
- Where the only position is outdoors with no climate control and you will not monitor temperature. A frozen or overheated spray is worse than none, because someone will rely on it.
- Where no one owns restocking and expiry. Machines that sit empty damage trust in the service.
- Where the goal is engagement, not access. If the point is a conversation, referral or training, a staffed outreach session does that; a machine can only link to it.
Frequently asked questions
Is it legal to put Narcan in a vending machine?
In the US, Narcan 4 mg nasal spray and RiVive 3 mg nasal spray were approved by the FDA for over-the-counter sale in 2023, so they can be sold or given away without a prescription, including from a machine. Other naloxone products may still be prescription-only, so check the label of the exact product. In Australia, naloxone is free without prescription under the Take Home Naloxone program through approved providers and authorised alternative suppliers, and each state or territory decides the non-pharmacy settings, so a machine runs as part of an approved supplier’s program. Elsewhere, ask the medicines regulator. KioskForce builds the machine to the requirement you state and does not certify legal compliance.
Are naloxone vending machines free?
Usually. Public health vending machines that dispense naloxone are usually run by a health department, harm-reduction service, university or other community health program, and give the medicine away at no cost so price is never a barrier. Some machines also sell other items, as in a university health vending machine that offered free naloxone alongside reduced-price emergency contraception. Paid naloxone vending is possible where the product is over-the-counter, but programs aimed at people at risk of overdose rarely charge. The cost of the machine, the stock and restocking is carried by the program and its funders.
Do naloxone vending machines need to be refrigerated?
No, but they do need temperature control in the sense of siting and monitoring. The current US Narcan label says to store it between 2 and 25 degrees Celsius, not to freeze it, to avoid heat above 40 degrees and to protect it from light; earlier label versions also warned that a frozen device will not spray. A cabinet indoors in a conditioned building usually meets that. An outdoor or unconditioned position in a hot or cold climate needs a cabinet with active temperature control and a logged temperature sensor with alerts. Check the label of the exact product you stock.
Do naloxone vending machines work?
The evidence is promising but still thin. A 2022 study in Annals of Medicine found that, in the 12 months after naloxone was added to public health vending machines in Clark County, Nevada, there were 229 opioid overdose deaths against 270 forecast, suggesting 41 deaths averted. That is an association, not proof of cause. A 2025 systematic review found high feasibility and acceptability for harm-reduction vending machines, with use concentrated outside business hours, and two articles reporting fewer fatal overdoses after naloxone machines were introduced. Most published studies measure uptake rather than outcomes.
Should a naloxone vending machine ask for ID or registration?
Usually not much. A scoping review of harm-reduction vending machines recommends allowing anonymous use, round-the-clock access and data collection. People at risk of overdose, and the friends and family who would use naloxone on them, are often reluctant to identify themselves. Common designs are a free push-button vend with a per-vend limit, a short anonymous on-screen question for evaluation data, or a program card or code where the service already registers clients. If your funder needs counts of unique users, a code issued on a phone can provide them without putting any personal data on the machine.
How much does a naloxone vending machine cost?
KioskForce compact wall-mount machines are published at about US$800 to US$1,500 per unit depending on configuration, and floor-standing machines start higher. Options that matter for naloxone add to that: a touchscreen for questions and instructions, cellular connectivity, temperature monitoring with alerts, and a cloud platform for program reporting. On a published free-vend project with a code and monthly quota, the software build was listed at US$11,000 with about US$200 a month to run. The naloxone itself, restocking labour, connectivity and evaluation are program running costs on top.
Where are naloxone vending machines placed?
Wherever people at risk of overdose, or people likely to witness one, pass at hours when a pharmacy or service is closed. Published examples include syringe services programs, needle and syringe programs and university buildings, and programs also use other community health and service sites. The best position is lit, sheltered, reachable at any hour and not so exposed that people are seen using it. Avoid unconditioned outdoor positions unless the cabinet has active temperature control and monitoring.
References
- US Food and Drug Administration — “FDA Approves First Over-the-Counter Naloxone Nasal Spray” (29 March 2023). https://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-naloxone-nasal-spray
- US Food and Drug Administration — “FDA Approves Second Over-the-Counter Naloxone Nasal Spray Product” (28 July 2023). https://www.fda.gov/news-events/press-announcements/fda-approves-second-over-counter-naloxone-nasal-spray-product
- DailyMed (US National Library of Medicine) — “NARCAN (naloxone hydrochloride) nasal spray”, current label, storage and handling (accessed 3 October 2026). https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0ebc83d-2892-40de-bc0a-775ce90b30db
- US Food and Drug Administration — “NARCAN (naloxone hydrochloride) nasal spray, prescribing information”, section 16 (2023). https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208411s007lbl.pdf
- Australian Government Department of Health, Disability and Ageing — “About the Take Home Naloxone program” (accessed 2 October 2026). https://www.health.gov.au/our-work/take-home-naloxone-program/about-the-take-home-naloxone-program
- Allen ST et al. — “Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada”, Annals of Medicine (2022). https://doi.org/10.1080/07853890.2022.2121418
- Russell E et al. — “A scoping review of implementation considerations for harm reduction vending machines”, Harm Reduction Journal (2023). https://doi.org/10.1186/s12954-023-00765-2
- Zhang A et al. — “Vending machines for reducing harm associated with substance use and use disorders, and co-occurring conditions: a systematic review”, Harm Reduction Journal (2025). https://doi.org/10.1186/s12954-025-01236-6
- Paa A et al. — “Deploying health vending machines to increase access to naloxone and emergency contraceptives at a large Midwestern University (October 2024–May 2025)”, Journal of American College Health (2026). https://doi.org/10.1080/07448481.2026.2626140
Related
- Medicine and health vending machines — the cluster hub.
- Are medicine vending machines legal?
- Temperature control for medicine vending
- How free-vend health programs work
- HIV self-test vending machines
- Harm reduction vending machines — the policy background and tender requirements.
- Public health vending — the products and coil setups we configure.
Talk to us about a naloxone vending machine
Send the products and carton sizes, the sites and their temperature ranges, the access model and what your funder needs reported. We will come back with a cabinet, a control model and a price.
Project brief · 60 seconds
What are we building together?
Three quick steps. Your brief goes straight to the engineers who design, build and support KioskForce systems.
